Differences in outcome between these studies may be due to differences in p16 KO models used (p16-deficient mice in the latter study died prematurely due to spontaneous tumor formation in lymphoid organs) and suggest the need for further studies to delineate mechanisms regulated by p16 that contribute to pathogenic processes in COPD. Here, CDKN2A is linked to chronic obstructive pulmonary disease.